Abstract:
A method for the preparation of omega lactams is disclosed, more particularly epsilon caprolactam or a precursor thereof (such as cyclohexanone oxime), using as the starting material a cyclomethylene ketene, with the simultaneous formation of side products such as cyclohexanecarboxylic acid, wherein an adduct is preliminarly formed between cyclomethylene ketene and sulphur dioxide. The adduct is then reacted with a nitrosating agent so as to obtain, under the appropriate reaction conditions, the expected lactam, more specifically epsilon caprolactam.
Abstract:
CYCLODODECYLMETHYL CYCLODOECANECARBOXYLATE IS DISCLOSED AS A NOVEL COMPOSITION OF MATTER WHICH MAY BE NITROSATED WITH NITROSYLSULFURIC ACID TO LAURINLACTAM. THE LACTAM IS CONVERTED BY CONVENTIONAL METHODS INTO NYLON 12. NYLON 12 IS BECOMING AN INCREASINGLY IMPORTANT POLYMER COMPOSITION FOR THE MANUFACTURE OF MOLDED ARTICLES, FIBERS AND THE LIKE. THE PRESENT INVENTION RELATES TO A NOVEL ESTER COMPOSITION OF MATTER WHICH MAY BE EMPLOYED IN THE SYNTHESIS OF LAURINLACTAM WHICH IN TURN IS USED IN THE MANFACTURE OF NYLON 12. THE PRESENT INVENTION ALSO RELATES TO A METHOD FOR MANUFACTURING SUCH ESTER COMPOSITIONS.
Abstract:
A PROCESS FOR PRODUCING LACTAMS FROM CYCLOALKANES IS DISCLOSED. CYCLOALKANES ARE REACTED WITH NITROSYL CHLORIDE WHILE SUBJECTED TO IRRADIATION, IN THE PRESENCE OF A NITRILE WHICH DOES NOT CONTAIN ANY METHYLENE GROUPS CAPABLE OF REACTING WITH NITROSYL UNDER THE REACTION CONDITIONS. WLACTAMS ARE DIRECTLY PRODUCED BY HEATING THE REACTION PRODUCT.
Abstract:
The present invention relates to certain salts of a 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (Compound I) which have been found to have improved properties. In particular the present invention relates to the citrate salt of this compound. The invention also relates to pharmaceutical compositions containing the citrate salt and methods of use of the citrate salt in the treatment of certain medical conditions.
Abstract:
A method for production of caprolactam. The method involves: (a) reacting air with ammonia gas in an ammonia conversion zone to produce nitric oxide; (b) oxidizing at least a portion of the nitric oxide to nitrogen dioxide to produce an NOx-rich process gas stream; (c) reactively absorbing the NOx-rich gas stream with phosphoric acid containing solution in an absorption zone to form nitrate ions; (d) contacting the nitrate ions with air in a degassing zone to produce a nitrate-rich aqueous process stream; (e) reducing the nitrate-rich aqueous stream with hydrogen in the presence of phosphoric acid to produce hydroxylammonium phosphate; (f) oximating the hydroxylammonium phosphate with cyclohexanone to produce cyclohexanone oxime; and (g) converting the cyclohexanone oxime to caprolactam. According to the invention, supplemental oxygen is added downstream of the ammonia conversion zone to increase the quantity and rate of formation of nitrogen dioxide in the NOx-rich process gas stream.
Abstract:
A METHOD FOR PREPARAING LACTAMS BY THE STEPS OF (1) CLEAVING AND ESTERIFYING A CYCLIC ALPHA-NITROKETONE WITH AN ALCOHOL TO FORM AN ALKYL OMEGA-NITROESTER AND (2) CATALYST HYDROGENATING AND CYCLIZING THE NITROESTER TO A LACTAM.